Dago Mazur

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

Joachim Stangier, Karin Rathgen, Hildegard Stähle et al. · Clinical Pharmacokinetics · 2010 · 721 citations

Oral Dabigatran Etexilate, Pharmacological Study, Medicine +6

Single‐Dose and Steady‐State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2–093) in Healthy Elderly and Young Subjects

Luís Almeida, Amílcar Falcão, Joana Maia et al. · The Journal of Clinical Pharmacology · 2005 · 101 citations

Therapeutic Drug Monitoring, Geriatrics, Steady‐state Pharmacokinetics +8

Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2‐093), a new voltage‐gated sodium channel blocker

Amílcar Falcão, Joana Maia, Luís Almeida et al. · Biopharmaceutics & Drug Disposition · 2007 · 53 citations · Full text

Diminished Ciprofloxacin-Induced Chondrotoxicity by Supplementation with Magnesium and Vitamin E in Immature Rats

Kerstin Pfister, Dago Mazur, Jürgen Vormann et al. · Antimicrobial Agents and Chemotherapy · 2007 · 30 citations · Full text

Nutrition, Lipid Peroxidation, Osteoporosis +17

Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation.

Dago Mazur, B S Schug, G Evers et al. · PubMed · 1999 · 23 citations

Pharmaceutical Science, New 600, Medicine +11